Loading…

Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway

The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-α, interleukin-4, t...

Full description

Saved in:
Bibliographic Details
Published in:International journal of hematology 2008-03, Vol.87 (2), p.189-194
Main Authors: Yu, Hong-Nu, Lee, Young-Rae, Noh, Eun-Mi, Lee, Kyung-Sun, Song, Eun-Kyung, Han, Myung-Kwan, Lee, Yong-Chul, Yim, Chang-Yeol, Park, Jinny, Kim, Byeong-Soo, Lee, Sung-Ho, Lee, Seung Jin, Kim, Jong-Suk
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3
cites cdi_FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3
container_end_page 194
container_issue 2
container_start_page 189
container_title International journal of hematology
container_volume 87
creator Yu, Hong-Nu
Lee, Young-Rae
Noh, Eun-Mi
Lee, Kyung-Sun
Song, Eun-Kyung
Han, Myung-Kwan
Lee, Yong-Chul
Yim, Chang-Yeol
Park, Jinny
Kim, Byeong-Soo
Lee, Sung-Ho
Lee, Seung Jin
Kim, Jong-Suk
description The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-α, interleukin-4, tumor necrosis factor-α (TNF-α), and dimethyl sulfoxide (DMSO) as a single agent or in combination with each other. Here, we show that a combination of TNF-α with DMSO shows a synergic effect on HL-60 cell differentiation through the activation of ERK pathway. TNF-α enhanced CD11b expression and percent of cell population in the G 1 phase induced by DMSO, which are hallmarks for HL-60 cell differentiation. Inhibition of ERK pathway abolished the synergic effect of TNF-α in combination with DMSO on HL-60 differentiation, but the inhibition NF-κB pathway did not. These results suggest that TNF-α synergistically increases DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK-signaling pathway.
doi_str_mv 10.1007/s12185-008-0037-z
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1007_s12185_008_0037_z</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>18256785</sourcerecordid><originalsourceid>FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EomV5AC7IF46mHseJnSOCQlFbgVjOkeuFpmqTyk7Y3ooX4ZlwlQpuHEZzmO8fez6EToCeA6ViEICBTAmlMlYiyOcO6oPMUpIIwXdRn-YsJakA2kMHISwoBUG52Ec9kCzNhEz76P2pXdUeV1b7OpQBO6Wb2pPvL2yruaq0Dfhq-nhHysq02hpsSuest1VTqqasK1w7PJqQjGJtl8uAm7mv25d57BbHTeXrLzV8GA-mF_djvFbN_E19HKE9p5bBHm_7IXq-Hj5djsjk7ub28mJCNGdpQ3IwkCpnrBOSz3IuBQPNIf4-yyhP8lzNIDM5JIpFGU5zbpVNGAgJhppcJ4cIur2bA4O3rlj7cqX8RwG02FgsOotFtFhsLBafMXPaZdbtbGXNX2KrLQJnW0AFrZbOR1Nl-OUYZRIEl5FjHRfiqHqxvljUra_ivf-8_gNMWIrX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway</title><source>Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List</source><creator>Yu, Hong-Nu ; Lee, Young-Rae ; Noh, Eun-Mi ; Lee, Kyung-Sun ; Song, Eun-Kyung ; Han, Myung-Kwan ; Lee, Yong-Chul ; Yim, Chang-Yeol ; Park, Jinny ; Kim, Byeong-Soo ; Lee, Sung-Ho ; Lee, Seung Jin ; Kim, Jong-Suk</creator><creatorcontrib>Yu, Hong-Nu ; Lee, Young-Rae ; Noh, Eun-Mi ; Lee, Kyung-Sun ; Song, Eun-Kyung ; Han, Myung-Kwan ; Lee, Yong-Chul ; Yim, Chang-Yeol ; Park, Jinny ; Kim, Byeong-Soo ; Lee, Sung-Ho ; Lee, Seung Jin ; Kim, Jong-Suk</creatorcontrib><description>The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-α, interleukin-4, tumor necrosis factor-α (TNF-α), and dimethyl sulfoxide (DMSO) as a single agent or in combination with each other. Here, we show that a combination of TNF-α with DMSO shows a synergic effect on HL-60 cell differentiation through the activation of ERK pathway. TNF-α enhanced CD11b expression and percent of cell population in the G 1 phase induced by DMSO, which are hallmarks for HL-60 cell differentiation. Inhibition of ERK pathway abolished the synergic effect of TNF-α in combination with DMSO on HL-60 differentiation, but the inhibition NF-κB pathway did not. These results suggest that TNF-α synergistically increases DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK-signaling pathway.</description><identifier>ISSN: 0925-5710</identifier><identifier>EISSN: 1865-3774</identifier><identifier>DOI: 10.1007/s12185-008-0037-z</identifier><identifier>PMID: 18256785</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Biological and medical sciences ; Cell Differentiation - drug effects ; Dimethyl Sulfoxide - pharmacology ; Drug Synergism ; Drug Therapy, Combination ; Granulocyte Precursor Cells - drug effects ; Hematologic and hematopoietic diseases ; Hematology ; HL-60 Cells ; Humans ; Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis ; MAP Kinase Signaling System - drug effects ; Medical sciences ; Medicine ; Medicine &amp; Public Health ; Mitogen-Activated Protein Kinase 1 - drug effects ; Mitogen-Activated Protein Kinase 3 - drug effects ; Oncology ; Original Article ; Phosphorylation - drug effects ; Tumor Necrosis Factor-alpha - pharmacology</subject><ispartof>International journal of hematology, 2008-03, Vol.87 (2), p.189-194</ispartof><rights>The Japanese Society of Hematology 2008</rights><rights>2008 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3</citedby><cites>FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=20281748$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18256785$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yu, Hong-Nu</creatorcontrib><creatorcontrib>Lee, Young-Rae</creatorcontrib><creatorcontrib>Noh, Eun-Mi</creatorcontrib><creatorcontrib>Lee, Kyung-Sun</creatorcontrib><creatorcontrib>Song, Eun-Kyung</creatorcontrib><creatorcontrib>Han, Myung-Kwan</creatorcontrib><creatorcontrib>Lee, Yong-Chul</creatorcontrib><creatorcontrib>Yim, Chang-Yeol</creatorcontrib><creatorcontrib>Park, Jinny</creatorcontrib><creatorcontrib>Kim, Byeong-Soo</creatorcontrib><creatorcontrib>Lee, Sung-Ho</creatorcontrib><creatorcontrib>Lee, Seung Jin</creatorcontrib><creatorcontrib>Kim, Jong-Suk</creatorcontrib><title>Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway</title><title>International journal of hematology</title><addtitle>Int J Hematol</addtitle><addtitle>Int J Hematol</addtitle><description>The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-α, interleukin-4, tumor necrosis factor-α (TNF-α), and dimethyl sulfoxide (DMSO) as a single agent or in combination with each other. Here, we show that a combination of TNF-α with DMSO shows a synergic effect on HL-60 cell differentiation through the activation of ERK pathway. TNF-α enhanced CD11b expression and percent of cell population in the G 1 phase induced by DMSO, which are hallmarks for HL-60 cell differentiation. Inhibition of ERK pathway abolished the synergic effect of TNF-α in combination with DMSO on HL-60 differentiation, but the inhibition NF-κB pathway did not. These results suggest that TNF-α synergistically increases DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK-signaling pathway.</description><subject>Biological and medical sciences</subject><subject>Cell Differentiation - drug effects</subject><subject>Dimethyl Sulfoxide - pharmacology</subject><subject>Drug Synergism</subject><subject>Drug Therapy, Combination</subject><subject>Granulocyte Precursor Cells - drug effects</subject><subject>Hematologic and hematopoietic diseases</subject><subject>Hematology</subject><subject>HL-60 Cells</subject><subject>Humans</subject><subject>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</subject><subject>MAP Kinase Signaling System - drug effects</subject><subject>Medical sciences</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Mitogen-Activated Protein Kinase 1 - drug effects</subject><subject>Mitogen-Activated Protein Kinase 3 - drug effects</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Phosphorylation - drug effects</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><issn>0925-5710</issn><issn>1865-3774</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><recordid>eNp9kMlOwzAQhi0EomV5AC7IF46mHseJnSOCQlFbgVjOkeuFpmqTyk7Y3ooX4ZlwlQpuHEZzmO8fez6EToCeA6ViEICBTAmlMlYiyOcO6oPMUpIIwXdRn-YsJakA2kMHISwoBUG52Ec9kCzNhEz76P2pXdUeV1b7OpQBO6Wb2pPvL2yruaq0Dfhq-nhHysq02hpsSuest1VTqqasK1w7PJqQjGJtl8uAm7mv25d57BbHTeXrLzV8GA-mF_djvFbN_E19HKE9p5bBHm_7IXq-Hj5djsjk7ub28mJCNGdpQ3IwkCpnrBOSz3IuBQPNIf4-yyhP8lzNIDM5JIpFGU5zbpVNGAgJhppcJ4cIur2bA4O3rlj7cqX8RwG02FgsOotFtFhsLBafMXPaZdbtbGXNX2KrLQJnW0AFrZbOR1Nl-OUYZRIEl5FjHRfiqHqxvljUra_ivf-8_gNMWIrX</recordid><startdate>20080301</startdate><enddate>20080301</enddate><creator>Yu, Hong-Nu</creator><creator>Lee, Young-Rae</creator><creator>Noh, Eun-Mi</creator><creator>Lee, Kyung-Sun</creator><creator>Song, Eun-Kyung</creator><creator>Han, Myung-Kwan</creator><creator>Lee, Yong-Chul</creator><creator>Yim, Chang-Yeol</creator><creator>Park, Jinny</creator><creator>Kim, Byeong-Soo</creator><creator>Lee, Sung-Ho</creator><creator>Lee, Seung Jin</creator><creator>Kim, Jong-Suk</creator><general>Springer Japan</general><general>Springer</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20080301</creationdate><title>Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway</title><author>Yu, Hong-Nu ; Lee, Young-Rae ; Noh, Eun-Mi ; Lee, Kyung-Sun ; Song, Eun-Kyung ; Han, Myung-Kwan ; Lee, Yong-Chul ; Yim, Chang-Yeol ; Park, Jinny ; Kim, Byeong-Soo ; Lee, Sung-Ho ; Lee, Seung Jin ; Kim, Jong-Suk</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Biological and medical sciences</topic><topic>Cell Differentiation - drug effects</topic><topic>Dimethyl Sulfoxide - pharmacology</topic><topic>Drug Synergism</topic><topic>Drug Therapy, Combination</topic><topic>Granulocyte Precursor Cells - drug effects</topic><topic>Hematologic and hematopoietic diseases</topic><topic>Hematology</topic><topic>HL-60 Cells</topic><topic>Humans</topic><topic>Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis</topic><topic>MAP Kinase Signaling System - drug effects</topic><topic>Medical sciences</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Mitogen-Activated Protein Kinase 1 - drug effects</topic><topic>Mitogen-Activated Protein Kinase 3 - drug effects</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Phosphorylation - drug effects</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yu, Hong-Nu</creatorcontrib><creatorcontrib>Lee, Young-Rae</creatorcontrib><creatorcontrib>Noh, Eun-Mi</creatorcontrib><creatorcontrib>Lee, Kyung-Sun</creatorcontrib><creatorcontrib>Song, Eun-Kyung</creatorcontrib><creatorcontrib>Han, Myung-Kwan</creatorcontrib><creatorcontrib>Lee, Yong-Chul</creatorcontrib><creatorcontrib>Yim, Chang-Yeol</creatorcontrib><creatorcontrib>Park, Jinny</creatorcontrib><creatorcontrib>Kim, Byeong-Soo</creatorcontrib><creatorcontrib>Lee, Sung-Ho</creatorcontrib><creatorcontrib>Lee, Seung Jin</creatorcontrib><creatorcontrib>Kim, Jong-Suk</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>International journal of hematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yu, Hong-Nu</au><au>Lee, Young-Rae</au><au>Noh, Eun-Mi</au><au>Lee, Kyung-Sun</au><au>Song, Eun-Kyung</au><au>Han, Myung-Kwan</au><au>Lee, Yong-Chul</au><au>Yim, Chang-Yeol</au><au>Park, Jinny</au><au>Kim, Byeong-Soo</au><au>Lee, Sung-Ho</au><au>Lee, Seung Jin</au><au>Kim, Jong-Suk</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway</atitle><jtitle>International journal of hematology</jtitle><stitle>Int J Hematol</stitle><addtitle>Int J Hematol</addtitle><date>2008-03-01</date><risdate>2008</risdate><volume>87</volume><issue>2</issue><spage>189</spage><epage>194</epage><pages>189-194</pages><issn>0925-5710</issn><eissn>1865-3774</eissn><abstract>The differentiation of promyelocytic leukemic cells into mature cells is the major strategy for drug-based treatment of leukemia. Higher efficient methods to differentiate promyelocytic leukemic cells have been developed using various differentiation inducers including interferon-α, interleukin-4, tumor necrosis factor-α (TNF-α), and dimethyl sulfoxide (DMSO) as a single agent or in combination with each other. Here, we show that a combination of TNF-α with DMSO shows a synergic effect on HL-60 cell differentiation through the activation of ERK pathway. TNF-α enhanced CD11b expression and percent of cell population in the G 1 phase induced by DMSO, which are hallmarks for HL-60 cell differentiation. Inhibition of ERK pathway abolished the synergic effect of TNF-α in combination with DMSO on HL-60 differentiation, but the inhibition NF-κB pathway did not. These results suggest that TNF-α synergistically increases DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK-signaling pathway.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>18256785</pmid><doi>10.1007/s12185-008-0037-z</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0925-5710
ispartof International journal of hematology, 2008-03, Vol.87 (2), p.189-194
issn 0925-5710
1865-3774
language eng
recordid cdi_crossref_primary_10_1007_s12185_008_0037_z
source Springer Nature:Jisc Collections:Springer Nature Read and Publish 2023-2025: Springer Reading List
subjects Biological and medical sciences
Cell Differentiation - drug effects
Dimethyl Sulfoxide - pharmacology
Drug Synergism
Drug Therapy, Combination
Granulocyte Precursor Cells - drug effects
Hematologic and hematopoietic diseases
Hematology
HL-60 Cells
Humans
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
MAP Kinase Signaling System - drug effects
Medical sciences
Medicine
Medicine & Public Health
Mitogen-Activated Protein Kinase 1 - drug effects
Mitogen-Activated Protein Kinase 3 - drug effects
Oncology
Original Article
Phosphorylation - drug effects
Tumor Necrosis Factor-alpha - pharmacology
title Tumor necrosis factor-α enhances DMSO-induced differentiation of HL-60 cells through the activation of ERK/MAPK pathway
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T11%3A46%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tumor%20necrosis%20factor-%CE%B1%20enhances%20DMSO-induced%20differentiation%20of%20HL-60%20cells%20through%20the%20activation%20of%20ERK/MAPK%20pathway&rft.jtitle=International%20journal%20of%20hematology&rft.au=Yu,%20Hong-Nu&rft.date=2008-03-01&rft.volume=87&rft.issue=2&rft.spage=189&rft.epage=194&rft.pages=189-194&rft.issn=0925-5710&rft.eissn=1865-3774&rft_id=info:doi/10.1007/s12185-008-0037-z&rft_dat=%3Cpubmed_cross%3E18256785%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c425t-91d15afdef784b948721c415676604399ab16d913a2121fc44eae321781d0d9c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/18256785&rfr_iscdi=true